TY - JOUR
T1 - Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
AU - Bras, Jose
AU - Guerreiro, Rita
AU - Darwent, Lee
AU - Parkkinen, Laura
AU - Ansorge, Olaf
AU - Escott-Price, Valentina
AU - Hernandez, Dena G
AU - Nalls, Michael A
AU - Clark, Lorraine N
AU - Honig, Lawrence S
AU - Marder, Karen
AU - Van Der Flier, Wiesje M
AU - Lemstra, Afina
AU - Scheltens, Philip
AU - Rogaeva, Ekaterina
AU - St George-Hyslop, Peter
AU - Londos, Elisabet
AU - Zetterberg, Henrik
AU - Ortega-Cubero, Sara
AU - Pastor, Pau
AU - Ferman, Tanis J
AU - Graff-Radford, Neill R
AU - Ross, Owen A
AU - Barber, Imelda
AU - Braae, Anne
AU - Brown, Kristelle
AU - Morgan, Kevin
AU - Maetzler, Walter
AU - Berg, Daniela
AU - Troakes, Claire
AU - Al-Sarraj, Safa
AU - Lashley, Tammaryn
AU - Compta, Yaroslau
AU - Revesz, Tamas
AU - Lees, Andrew
AU - Cairns, Nigel
AU - Halliday, Glenda M
AU - Mann, David
AU - Pickering-Brown, Stuart
AU - Dickson, Dennis W
AU - Singleton, Andrew
AU - Hardy, John
N1 - 081864, Wellcome Trust, United Kingdom089698, Wellcome Trust, United Kingdom089703, Wellcome Trust, United Kingdom100140, Wellcome Trust, United KingdomAG000951-12, NIA NIH HHS, United StatesG0701441, Medical Research Council, United KingdomJ-0901, Parkinson's UK, United KingdomK-1204, Parkinson's UK, United KingdomNS060113, NINDS NIH HHS, United StatesP50 NS072187, NINDS NIH HHS, United StatesP50AG008702, NIA NIH HHS, United StatesP50NS038370, NINDS NIH HHS, United StatesR01 NS078086, NINDS NIH HHS, United StatesR01 NS078086, NINDS NIH HHS, United StatesUL1TR000040, NCATS NIH HHS, United StatesWT089698, Wellcome Trust, United Kingdom, Canadian Institutes of Health Research, Canada, Medical Research Council, United Kingdom
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Clinical and neuropathological similarities between dementia with Lewy bodies (DLB), Parkinson's and Alzheimer's diseases (PD and AD, respectively) suggest that these disorders may share etiology. To test this hypothesis, we have performed an association study of 54 genomic regions, previously implicated in PD or AD, in a large cohort of DLB cases and controls. The cohort comprised 788 DLB cases and 2624 controls. To minimize the issue of potential misdiagnosis, we have also performed the analysis including only neuropathologically proven DLB cases (667 cases). The results show that the APOE is a strong genetic risk factor for DLB, confirming previous findings, and that the SNCA and SCARB2 loci are also associated after a study-wise Bonferroni correction, although these have a different association profile than the associations reported for the same loci in PD. We have previously shown that the p.N370S variant in GBA is associated with DLB, which, together with the findings at the SCARB2 locus, suggests a role for lysosomal dysfunction in this disease. These results indicate that DLB has a unique genetic risk profile when compared with the two most common neurodegenerative diseases and that the lysosome may play an important role in the etiology of this disorder. We make all these data available.
AB - Clinical and neuropathological similarities between dementia with Lewy bodies (DLB), Parkinson's and Alzheimer's diseases (PD and AD, respectively) suggest that these disorders may share etiology. To test this hypothesis, we have performed an association study of 54 genomic regions, previously implicated in PD or AD, in a large cohort of DLB cases and controls. The cohort comprised 788 DLB cases and 2624 controls. To minimize the issue of potential misdiagnosis, we have also performed the analysis including only neuropathologically proven DLB cases (667 cases). The results show that the APOE is a strong genetic risk factor for DLB, confirming previous findings, and that the SNCA and SCARB2 loci are also associated after a study-wise Bonferroni correction, although these have a different association profile than the associations reported for the same loci in PD. We have previously shown that the p.N370S variant in GBA is associated with DLB, which, together with the findings at the SCARB2 locus, suggests a role for lysosomal dysfunction in this disease. These results indicate that DLB has a unique genetic risk profile when compared with the two most common neurodegenerative diseases and that the lysosome may play an important role in the etiology of this disorder. We make all these data available.
U2 - 10.1093/hmg/ddu334
DO - 10.1093/hmg/ddu334
M3 - Article
C2 - 24973356
SN - 1460-2083
VL - 23
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 23
ER -